2 May, 2023Amolyt Pharma announces Phase 3 clinical trial of Eneboparatide for the treatment of hypoparathyroidism following positive end of Phase 2 Meeting with FDA
17 April, 2023Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
30 March, 2023Landmark New England Journal of Medicine publication reports positive results from PROMISE II pivotal trial showing that LimFlow System saves most patients with end-stage peripheral artery disease from major amputation
13 March, 2023Calliditas announces primary endpoint successfully met in Phase 3 NefIgArd trial evaluating Nefecon® in IgA nephropathy
22 February, 2023Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors